Fetal Growth Acceleration-Current Approach to the Big Baby Issue

Jan Modzelewski1, Anna Kajdy1, Katarzyna Muzyka-Placzyńska1

  • 1Department of Reproductive Health, Centre of Postgraduate Medical Education, 01-004 Warsaw, Poland.

Insights

Fetal overgrowth, or macrosomia, is linked to serious birth complications. Early detection using customized growth charts can identify at-risk pregnancies and improve outcomes.

Area of Science:

  • Perinatal Medicine
  • Maternal-Fetal Medicine
  • Neonatology

Background:

  • Fetal overgrowth is associated with significant perinatal complications like stillbirth, cesarean delivery, and shoulder dystocia.
  • Risk factors include maternal diabetes, obesity, and excessive gestational weight gain, but it also occurs in low-risk pregnancies.
  • Current definitions and detection methods for fetal overgrowth are debated, impacting risk stratification.

Purpose of the Study:

  • To review the evidence linking fetal overgrowth to adverse perinatal outcomes.
  • To discuss the role of detection methods in identifying at-risk pregnancies.
  • To propose a new classification for fetal overgrowth.

Main Methods:

  • A narrative review of existing literature.
  • PubMed search using terms like 'macrosomia' and 'large-for-gestational-age' combined with outcomes of interest.
  • Synthesis of evidence on fetal overgrowth and its associated complications.

Main Results:

  • Fetal overgrowth is associated with stillbirth, cesarean sections, shoulder dystocia, anal sphincter injury, and hemorrhage.
  • Customized growth charts aid in identifying fetuses and mothers at risk for these complications.
  • The relationship between fetal overgrowth and maternal factors like diabetes, weight, and gestational weight gain was examined.

Conclusions:

  • A significant portion of perinatal complications result from excessive fetal growth.
  • Fetal overgrowth should be recognized as a distinct and dangerous condition, termed Fetal Growth Acceleration.
  • Improved detection and classification are crucial for managing pregnancies with fetal overgrowth.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.6K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.9K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.3K